Baxter International Inc (BAX) Stock Price, Quote & News

Company Profile

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed system...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 224 948 2000

Website: www.baxter.com

Address:

One Baxter Parkway, Deerfield, United States

techniker Jun. 4 at 3:00 AM

$BAX hillrom acquisition was a turd

0 · Reply

DoomBot1 May. 30 at 1:34 PM

$BSX obsolete company, the next $BAX

0 · Reply

Peterke99 May. 29 at 9:58 AM

$BAX who was the worst CEO of Baxter? Without any doubt Joe Almeida. Is there allready a class action against him and his board?

0 · Reply

Windee May. 26 at 10:03 AM

$BAX Added. Now streamlined product mix with crazy deep value transformation. Got to love the new CEO - Andrew Hider - operational stabilization programme following massive corporate restructuring. Let’s go and turn this baby around!!

1 · Reply

OnlyFibs May. 24 at 10:56 PM

Everyone thought $BAX was dead money, but the monthly chart just printed a generational bounce off a 30-year ascending support line. With a fresh Q1 earnings beat and an 11% rip this week, the turnaround is officially here. 📈🧬 🐂 Bull Level: A clean weekly break over $20.00 triggers the institutional flow and unlocks the upside vacuum. 🐻 Bear Level: $17.50 is the absolute line in the sand. Respect the macro tape. #SwingTrading #ValueInvesting #BAX #hovdid

0 · Reply

Windee May. 22 at 6:22 PM

$BAX let’s see… new CEO driven to turn things around, out with the old in with the new shareholders agreed to offer $ cash incentives, new team fired up. OK boys wake up!

0 · Reply

FLTR8R May. 19 at 10:04 PM

$BAX I would not wanna be short this one...

0 · Reply

CapitalMonk May. 13 at 2:56 AM

$BAX Price: $17.89 (+2.05%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±1.57% RSI: 46.6 | Momentum: Moderate Volume: -37.2% vs avg Volatility: 2.66% Support: $16.17 | Resistance: $19.19 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

g_man_ May. 11 at 11:52 PM

$BAX time to tip my toe in

0 · Reply

ssdsddssd2 May. 11 at 4:39 PM

$BAX add more - 50+ in 2027

0 · Reply

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

AES ARW EXP EXPD HPQ IESC KHC

2026-05-28T10:56:32.000Z - 7 days ago

Baxter downgraded to Sell from Neutral at Citi

May 13, 2026, 2:20 PM EDT - 22 days ago

Baxter International Transcript: Bank of America Global Healthcare Conference 2026

May 5, 2026, 10:00 AM EDT - 4 weeks ago

Baxter International Transcript: AGM 2026

2026-05-04T09:15:09.000Z - 4 weeks ago

Baxter price target raised to $27 from $25 at Barclays

2026-05-01T13:39:22.000Z - 4 weeks ago

Baxter price target lowered to $17 from $19 at Goldman Sachs

Apr 30, 2026, 8:30 AM EDT - 5 weeks ago

Baxter International Earnings Call Transcript: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 5 weeks ago

Baxter International Slides: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 5 weeks ago

Baxter International Earnings release: Q1 2026

Apr 30, 2026, 8:30 AM EDT - 5 weeks ago

Baxter International Quarterly report: Q1 2026

Apr 30, 2026, 8:26 AM EDT - 5 weeks ago

Baxter beats quarterly expectations on strong demand for medical devices

Apr 30, 2026, 7:15 AM EDT - 5 weeks ago

Baxter Reports First-Quarter 2026 Results

Apr 29, 2026, 8:00 AM EDT - 5 weeks ago

Baxter International Proxy statement: Proxy filing

2026-04-13T13:15:57.000Z - 7 weeks ago

Baxter showcases Global Surgical Solutions portfolio at AORN Conference

Apr 13, 2026, 9:00 AM EDT - 7 weeks ago

Baxter Showcases Recent Innovations at AORN Global Surgical Conference & Expo 2026

Apr 8, 2026, 4:15 PM EDT - 2 months ago

Baxter to Host First-Quarter 2026 Financial Results Conference Call for Investors

2026-04-06T12:26:05.000Z - 2 months ago

Baxter price target lowered to $22 from $23 at Evercore ISI

Mar 31, 2026, 10:33 AM EDT - 2 months ago

These 20 stocks in the S&P 500 fell hardest during March

AMCR AXON BLDR CCL CNC DG EL

2026-03-30T12:52:31.000Z - 2 months ago

Baxter introduces IV Verify Line Labeling System

Mar 30, 2026, 8:30 AM EDT - 2 months ago

Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings

Mar 25, 2026, 4:30 PM EDT - 2 months ago

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Mar 25, 2026, 9:00 AM EDT - 2 months ago

Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot

Mar 24, 2026, 9:48 AM EDT - 2 months ago

EU regulator warns of shortage in Baxter's cancer treatment until early 2027

Mar 23, 2026, 8:00 AM EDT - 2 months ago

Baxter International Proxy statement: Proxy filing

Mar 23, 2026, 8:00 AM EDT - 2 months ago

Baxter International Proxy statement: Proxy filing

2026-03-16T13:02:30.000Z - 2 months ago

Baxter CFO Joel Grade to depart

2026-03-16T13:01:53.000Z - 2 months ago

Baxter backs FY26 adjusted EPS view $1.85-$2.05, consensus $1.92

Mar 16, 2026, 8:45 AM EDT - 2 months ago

Baxter Announces CFO Transition

Mar 13, 2026, 8:00 AM EDT - 2 months ago

Baxter International Proxy statement: Proxy Filing

Mar 11, 2026, 1:00 PM EDT - 3 months ago

Baxter International Transcript: Barclays 28th Annual Global Healthcare Conference

2026-03-11T09:27:21.000Z - 3 months ago

Baxter price target lowered to $19 from $21 at Citi

Feb 26, 2026, 12:15 PM EST - 3 months ago

Baxter International Transcript: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day

2026-02-17T15:05:56.000Z - 3 months ago

Baxter price target lowered to $17 from $21 at Goldman Sachs

2026-02-16T12:55:46.000Z - 3 months ago

Baxter price target lowered to $19 from $21 at UBS

2026-02-13T13:41:06.000Z - 3 months ago

Baxter price target lowered to $20 from $22 at Deutsche Bank

2026-02-13T11:47:52.000Z - 3 months ago

Baxter price target lowered to $25 from $30 at Barclays

2026-02-12T20:55:16.000Z - 4 months ago

Baxter price target lowered to $19 from $21 at Jefferies

2026-02-12T20:45:37.000Z - 4 months ago

Baxter price target lowered to $20 from $22 at Stifel

Feb 12, 2026, 8:30 AM EST - 4 months ago

Baxter International Earnings Call Transcript: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Baxter International Earnings release: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Baxter International Annual report: Q4 2025

Feb 12, 2026, 8:30 AM EST - 4 months ago

Baxter International Slides: Q4 2025

Feb 12, 2026, 7:24 AM EST - 4 months ago

Baxter forecast 2026 profit below estimates

Feb 12, 2026, 7:15 AM EST - 4 months ago

Baxter Reports Fourth-Quarter 2025 Results

Jan 21, 2026, 5:00 PM EST - 4 months ago

Baxter to Host Fourth-Quarter 2025 Financial Results Conference Call for Investors

Jan 13, 2026, 9:00 AM EST - 5 months ago

Baxter Introduces the Dynamo Series, a New Smart Stretcher to Help Address Common Challenges in Hospital Settings

Jan 12, 2026, 5:15 PM EST - 5 months ago

Baxter International Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 5 months ago

Baxter International Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 8, 2026, 9:00 AM EST - 5 months ago

MUSC Health and Baxter Announce Strategic Partnership to Transform Bedside Care Delivery and Address Critical Nursing Challenges

Jan 6, 2026, 5:14 PM EST - 5 months ago

Baxter to Present at J.P. Morgan 2026 Healthcare Conference

Dec 12, 2025, 10:32 AM EST - 6 months ago

DOC HOLLYWOOD: A Psychiatrist Takes 3rd Place with Baxter's Brain at the American Film Market Pitch Conference

Dec 11, 2025, 8:30 AM EST - 6 months ago

Baxter Presents Real-World Data at American Society of Health System Pharmacists Meeting Demonstrating Smart Infusion Pump Electronic Medical Record (EMR) Integration May Improve Patient Safety and Nursing Bedside Productivity

Dec 4, 2025, 4:15 PM EST - 6 months ago

Baxter Announces Pricing of Tender Offers for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 4, 2025, 7:51 AM EST - 6 months ago

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Dec 2, 2025, 10:50 AM EST - 6 months ago

Baxter International Transcript: Evercore ISI 8th Annual HealthCONx Conference

Nov 19, 2025, 4:15 PM EST - 7 months ago

Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027

Nov 19, 2025, 8:54 AM EST - 7 months ago

Baxter Announces Tender Offers for 2026 Notes and 2027 Notes

Nov 18, 2025, 8:00 AM EST - 7 months ago

Baxter International Transcript: Jefferies London Healthcare Conference 2025

Nov 11, 2025, 4:30 PM EST - 7 months ago

Baxter Declares Quarterly Dividend

Nov 10, 2025, 8:15 AM EST - 7 months ago

BAXTER INTERNATIONAL INC. (NYSE: BAX) DEADLINE ALERT Bernstein Liebhard LLP Reminds Baxter International Inc. Investors of Upcoming Deadline

Nov 7, 2025, 8:45 AM EST - 7 months ago

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

Oct 30, 2025, 8:30 AM EDT - 7 months ago

Baxter International Earnings Call Transcript: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 7 months ago

Baxter International Quarterly report: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 7 months ago

Baxter International Earnings release: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 7 months ago

Baxter International Slides: Q3 2025

Oct 30, 2025, 8:27 AM EDT - 7 months ago

Medical products maker Baxter cuts annual profit forecast on persistent hurricane impact

techniker Jun. 4 at 3:00 AM

$BAX hillrom acquisition was a turd

0 · Reply

DoomBot1 May. 30 at 1:34 PM

$BSX obsolete company, the next $BAX

0 · Reply

Peterke99 May. 29 at 9:58 AM

$BAX who was the worst CEO of Baxter? Without any doubt Joe Almeida. Is there allready a class action against him and his board?

0 · Reply

Windee May. 26 at 10:03 AM

1 · Reply

OnlyFibs May. 24 at 10:56 PM

0 · Reply

Windee May. 22 at 6:22 PM

$BAX let’s see… new CEO driven to turn things around, out with the old in with the new shareholders agreed to offer $ cash incentives, new team fired up. OK boys wake up!

0 · Reply

FLTR8R May. 19 at 10:04 PM

$BAX I would not wanna be short this one...

0 · Reply

CapitalMonk May. 13 at 2:56 AM

0 · Reply

g_man_ May. 11 at 11:52 PM

$BAX time to tip my toe in

0 · Reply

ssdsddssd2 May. 11 at 4:39 PM

$BAX add more - 50+ in 2027

0 · Reply

MarketBeat May. 10 at 1:06 AM

https://marketbeat.com/a/8644597/ $BAX Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

0 · Reply

Bushpig May. 8 at 4:01 PM

$BAX POS going to zero, worst $1000.00 investment ever.

1 · Reply

Bushpig May. 8 at 4:01 PM

$BAX POS going to zero, worst $1000.00 investment ever

1 · Reply

Bushpig May. 8 at 3:35 PM

$BAX POS going to zero, worst $1000.00 investment ever!

0 · Reply

The_Gambl3r May. 7 at 3:09 AM

$LIVN $MDT $FMS $BAX $NUWE ** 👀👀

1 · Reply

Windee May. 5 at 2:17 PM

$BAX Down over 80% year to date. Looks like they’ll never recover. CAN’T FLOG A DEAD HORSE! Market share seems to have gone to $BDX $MRK $PFE & $ABT

1 · Reply

UmmHmmDaddy May. 4 at 8:37 PM

$BAX premium trash

0 · Reply

Windee May. 1 at 6:26 PM

$BAX Bought the dip. Let’s see how far she goes. What do you think? Maybe a turnaround?

0 · Reply

FLTR8R Apr. 30 at 2:18 PM

$BAX BANG!!!

0 · Reply

iNvEsTiNgiSEZ Apr. 30 at 2:02 PM

$BAX short every pop free money

2 · Reply

FLTR8R Apr. 30 at 1:37 PM

$BAX Buying with bith hands!!! Let's go!!!

0 · Reply

FLTR8R Apr. 30 at 11:34 AM

$BAX Bitch about to get re rated!!! LFG!!!

0 · Reply

Market Cap	9.05B
Revenue (ttm)	11.24B
Net Income (ttm)	-957.00M
EPS (ttm)	N/A
PE Ratio	8.65
Forward PE	9.38
Profit Margin	-8.51%
Debt to Equity Ratio	1.57

Volume	7,896,722
Avg Vol	8,583,274
Day's Range	N/A - N/A
Shares Out	516.47M
Stochastic %K	90%
Beta	0.62
Analysts	Sell
Price Target	$20.55